Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leukocyte function-associated antigen 3 (LFA-3), also known as CD58, is a cell surface adhesion molecule that plays a critical role in immune cell interactions. It serves as a ligand for the T lymphocyte CD2 glycoprotein, facilitating essential contacts between T cells and other cells. This interaction is crucial for thymocyte development, immune synapse formation and effective immune responses. Altered expression of LFA-3 has been implicated in diseases such as Burkitt's lymphoma, where reduced levels may help tumor cells escape immunosurveillance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leukocyte function-associated antigen 3 (LFA-3).